"Risks and Benefits of Phase I Trials: Twelve-years Experience from a Single Institution." by U. Swami

Selected Works of Santiago Aparo

Follow Contact

Article

Risks and Benefits of Phase I Trials: Twelve-years Experience from a Single Institution.

Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting (2011)

U. Swami, Albert Einstein College of Medicine
M. H. Ghalib, Montefiore Medical Center
I. Chaudhary, Montefiore Medical Center
J. Y. Hou
S. Aparo, Albert Einstein College of Medicine
M. H. Einstein, Albert Einstein College of Medicine
G. L. Goldberg, Albert Einstein College of Medicine
T. N. Elrafei
S. Gajavelli
B. Cohen
L. Rajdev, Montefiore Medical Center
A. Kaubisch, Memorial Sloan Kettering Cancer Center
M. Haigentz
S. Mani, University of Chicago
S. Goel, Montefiore Medical Center

Link

Abstract

Disciplines

Publication Date

June, 2011

DOI

10.1200/jco.2011.29.15_suppl.6098

Citation Information

U. Swami, M. H. Ghalib, I. Chaudhary, J. Y. Hou, et al.. "Risks and Benefits of Phase I Trials: Twelve-years Experience from a Single Institution." Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 29 Iss. 15 suppl. (2011) p. 6098 - 6098
Available at: http://works.bepress.com/santiago-aparo/14/